Skip to content

NARA

PanGenomic Health Inc

Access


ISIN

CA69842E2050

Bid

2.00

Mid

2.50

Ask

3.00

Key Information

Price Change
0.00%
Year High
4.50
Year Low
2.50
Last Trade
30 Nov 23
Market Cap
£2.62M
Par
0.00
Bid
2.00
Mid Price
2.50
Ask
3.00
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
105.0M
Sector
Healthcare

Prices in GBX except for Market Cap in GBP

About PanGenomic Health Inc

The Company is a precision health company that has developed a self-care digital platform to deliver personalised, evidence-based information about natural treatments to support mental health. The Company has three platforms: Nara App - a mental health mobile app which provides consumers with a knowledge base tailored to an individual's unique user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics and microbiomic data. indleap.com - and app and telehealth platform for holistirc mental wellness which grants users access to great audio content and blogs, a mental health tracker, and access to professional services for mental well-being. The Company's digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to a consumer's Nara App data in order to assist them to optimize the identification of appropriate natural remedies and monitor a patient's prognosis during treatment. Mindleap.com was acquired in November 2022 when the Company purchased the entire issued share capital for Mindleap Health Inc from Mydecine Innovations Group Inc.

PanGenomic Health IncAccess

Latest Trades

DateVolumePrice (GBX)Value (GBP)

30 Nov 23

16:04

12,5003.00375.00

30 Nov 23

16:04

12,5003.00375.00

30 Nov 23

15:55

12,5003.50437.50

30 Nov 23

15:54

12,5003.50437.50

30 Nov 23

15:53

12,5003.50437.50
View all trades

Latest Announcements & Notices

DateTitle

30 Nov 23

07:05

PanGenomic Health Inc - PanGenomic Health Announces Q3 Financial Results

30 Nov 23

07:00

PanGenomic Health Inc - Total Voting Rights

17 Nov 23

12:30

PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests

02 Nov 23

09:47

PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement

12 Apr 23

01:00

Market Notice - Admission to Trading
View all announcementsView all notices

Address

Registered Address

232 – 3800 Wesbrook Mall, Vancouver, British Columbia, V6S 2L9, Canada

Email

Phone

604-218-5788

Contacts

Corporate Adviser

Novum Securities, 2nd Floor, 7-10 Chandos Street, London, W1G 9DQ, United Kingdom

Registrar

Link Group, 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal